Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents; Reuters, December 6, 2022

Blake Brittain, Reuters ; Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

"Pfizer Inc (PFE.N) and its German partner, BioNTech SE (22UAy.DE), fired back at Moderna Inc (MRNA.O) on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal court and an order that Moderna's patents are invalid and not infringed.

Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic."

Moderna suing Pfizer over Covid vaccine technology; BBC News, August 26, 2022

Jim Reed, BBC News; Moderna suing Pfizer over Covid vaccine technology

"Moderna said it is suing Pfizer and its German partner BioNTech for patent infringement linked to the development of the first Covid-19 vaccines.

The US biotech company is alleging that mRNA technology it developed before the pandemic was copied.

The lawsuit, which is seeking unspecified financial damages, was filed in the US and Germany."

Pfizer Says Employee Stole Files With Covid Vaccine Secrets; Bloomberg Law, November 24, 2021

Kyle Jahner, Bloomberg Law; Pfizer Says Employee Stole Files With Covid Vaccine Secrets 

"Pfizer Inc. is alleging a “soon-to-be-former employee” misappropriated thousands of files, including documents with trade secrets related to its Covid-19 vaccine, in a California federal court lawsuit.

Chun Xiao (Sherry) Li allegedly uploaded more than 12,000 files including “scores” of documents with confidential information to a Google Drive account, Pfizer alleged in a complaint filed Tuesday in the U.S. District Court for the Southern District of California. The documents are said to pertain to a broad range of topics, including analysis of vaccine studies, operational goals, and development plans for new drugs...

“Pfizer takes the safeguarding of sensitive and confidential information very seriously. Protecting that information is critical to scientific innovation, ultimately enabling us to deliver breakthroughs for patients,” a company spokesman said.

Trade secrets present a thorny issue for the debate around waiving Covid-related IP rights. Disclosure of trade secrets could aid overseas manufacturers in producing copycat versions of vaccines created by Pfizer, which has spoken out against an international waiver on intellectual property protections on Covid-19 treatments and vaccines."

Pfizer agrees to let other companies make its COVID-19 pill; Associated Press, November 16, 2021

Maria Cheng, Associated Press ; Pfizer agrees to let other companies make its COVID-19 pill

"Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. 

In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population.""

Lloyd Conover, Inventor of Groundbreaking Antibiotic, Dies at 93; New York Times, March 12, 2017

Denise Gellene, New York Times; 

Lloyd Conover, Inventor of Groundbreaking Antibiotic, Dies at 93

"With tetracycline’s commercial success, however, came a slew of patent challenges. Three pharmaceutical companies claimed that their scientists had discovered tetracycline before Dr. Conover, although their patent applications were filed later. After Pfizer licensed tetracycline to its competitors to end the dispute, the federal government challenged the licensing deals as anticompetitive, along with the validity of the patent.

“I had essentially a second career, preparing for and giving depositions and testifying,” Dr. Conover wrote in a 1984 article in the journal Research Management.

At scientific meetings, he wrote, he felt a coolness from peers who thought that his patent claim was false. A federal appeals court in Philadelphia finally affirmed the patent — and, by extension, the licensing agreements — in 1982, three decades after Dr. Conover invented tetracycline."